T1	Participants 80 114	subjects with cardiovascular risk.
T2	Participants 441 581	two groups of middle-aged men differing in cardiovascular risk; 46 survivors of myocardial infarction before age 50 and 60 healthy controls.
T3	Participants 676 740	Twenty-eight patients and 58 controls completed the intervention
T4	Participants 1298 1335	subjects with the TT variant genotype
T5	Participants 1412 1436	subjects with low folate
T6	Participants 1649 1680	myocardial infarction survivors
T7	Participants 1857 1891	subjects with normal folate levels
T8	Participants 1908 1939	subjects with low folate levels
